• News

Cancer Clinical Trials Bounce Back After Significant COVID-19 Disruption

  • Cancer Health
  • New York, NY
  • (July 01, 2022)

Deborah Doroshow, MD, PhD, discusses her study at The Tisch Cancer Institute with The Dana-Farber Cancer Institute about how the COVID-19 pandemic caused substantial disruption to clinical trials for cancer treatment and care.

Learn more